The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles.

Superparamagnetic iron oxide (SPIO) nanoparticles are very useful in cell imaging; meanwhile, however, biosafety concerns associated with their use, especially on therapeutic stem cells, have arisen. Most studies of biosafety issues focus on whether the nanoparticles have deleterious effects. Here, we report that Ferucarbotran, an ionic SPIO, is not toxic to human mesenchymal stem cells (hMSCs) under the conditions of these experiments but instead increases cell growth. Ferucarbotran-promoted cell growth is due to its ability to diminish intracellular H2O2 through intrinsic peroxidase-like activity. Also, Ferucarbotran can accelerate cell cycle progression, which may be mediated by the free iron (Fe) released from lysosomal degradation and involves the alteration of Fe on the expression of the protein regulators of the cell cycle.

[1]  Heather Kalish,et al.  Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. , 2004, Blood.

[2]  S Moein Moghimi,et al.  Low and high molecular weight poly(l‐lysine)s/poly(l‐lysine)–DNA complexes initiate mitochondrial‐mediated apoptosis differently , 2005, FEBS letters.

[3]  Heather Kalish,et al.  Comparison of Transfection Agents in Forming Complexes with Ferumoxides, Cell Labeling Efficiency, and Cellular Viability , 2004, Molecular imaging.

[4]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[5]  W. K. Miskimins,et al.  Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1). , 2000, Experimental cell research.

[6]  L. Juillerat-Jeanneret,et al.  Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. , 2005, Biomaterials.

[7]  Ying Zhang,et al.  Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. , 2002, Cancer research.

[8]  A. Arbab,et al.  Labeling of cells with ferumoxides–protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells , 2005, NMR in biomedicine.

[9]  Xavier Montet,et al.  Interaction of Functionalized Superparamagnetic Iron Oxide Nanoparticles with Brain Structures , 2006, Journal of Pharmacology and Experimental Therapeutics.

[10]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[11]  Bobbi K Lewis,et al.  A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging , 2005, NMR in biomedicine.

[12]  A. Tordai,et al.  Effects of iron-depletion on cell cycle progression in normal human T lymphocytes: selective inhibition of the appearance of the cyclin A-associated component of the p33cdk2 kinase. , 1995, Blood.

[13]  Dar-Bin Shieh,et al.  Characterization of aqueous dispersions of Fe(3)O(4) nanoparticles and their biomedical applications. , 2005, Biomaterials.

[14]  A. Gupta,et al.  Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies , 2004, IEEE Transactions on NanoBioscience.

[15]  R. Weinberg,et al.  The role of RB in cell cycle control. , 1995, Progress in cell cycle research.

[16]  J. Mazurkiewicz,et al.  Mitochondrial or cytosolic catalase reverses the MnSOD-dependent inhibition of proliferation by enhancing respiratory chain activity, net ATP production, and decreasing the steady state levels of H(2)O(2). , 2000, Free radical biology & medicine.

[17]  D. Richardson,et al.  Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  Ajay Kumar Gupta,et al.  Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. , 2005, Biomaterials.

[19]  J Lucas,et al.  Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle. , 1993, Cancer research.

[20]  C. Nicco,et al.  Differential modulation of normal and tumor cell proliferation by reactive oxygen species. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[21]  Heather Kalish,et al.  Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. , 2003, Radiology.

[22]  A. Levine,et al.  The p53 tumour suppressor gene , 1991, Nature.

[23]  K. Fukuchi,et al.  Iron deprivation results in an increase in p53 expression. , 1995, Biological chemistry Hoppe-Seyler.

[24]  Ergin Atalar,et al.  In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction , 2003, Circulation.

[25]  J. Bulte,et al.  Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. , 2002, Academic radiology.

[26]  Yu Zhang,et al.  Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. , 2007, Nature nanotechnology.

[27]  R. Burdon.  Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. , 1995, Free radical biology & medicine.

[28]  Jeff W M Bulte,et al.  Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis , 2004, NMR in biomedicine.

[29]  M. Freedman,et al.  Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation. , 1984, Blood.

[30]  Peter van Gelderen,et al.  Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells , 2001, Nature Biotechnology.

[31]  R Weissleder,et al.  Magnetically labeled cells can be detected by MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[32]  J. Gearhart,et al.  In vitro toxicity of nanoparticles in BRL 3A rat liver cells. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[33]  K. Kulp,et al.  Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells. , 1996, Experimental cell research.

[34]  G. Andrei,et al.  Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors. , 2000, The Journal of investigative dermatology.

[35]  K. Landfester,et al.  Carboxylated Superparamagnetic Iron Oxide Particles Label Cells Intracellularly Without Transfection Agents , 2008, Molecular Imaging and Biology.

[36]  A. C. Hunter.  Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity. , 2006, Advanced drug delivery reviews.